Petra Frick Née Weber

Title: Petra Frick Née Weber: Innovator in Neurodegenerative Disease Research

Introduction

Petra Frick Née Weber is a notable inventor based in Munich, Germany. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patenting efforts. Her work focuses on developing compounds that can inhibit the aggregation of proteins associated with various diseases.

Latest Patents

Petra Frick Née Weber holds a patent for a drug aimed at inhibiting the aggregation of proteins involved in diseases linked to protein aggregation and neurodegenerative diseases. The invention relates to a compound represented by formula (E) for use in the treatment or prevention of such diseases. Additionally, it encompasses pharmaceutical and diagnostic compositions that include the compound, as well as a method for imaging deposits of aggregated protein. A kit for preparing a detectably labeled compound is also disclosed in her patent.

Career Highlights

Throughout her career, Petra has worked with prestigious institutions such as Ludwig-Maximilians-Universität München and Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. Her research has been instrumental in advancing the understanding of protein aggregation and its implications in neurodegenerative diseases.

Collaborations

Petra has collaborated with esteemed colleagues, including Armin Giese and Uwe Bertsch, to further her research and enhance the impact of her findings in the scientific community.

Conclusion

Petra Frick Née Weber's contributions to the field of neurodegenerative diseases through her innovative patent and collaborative efforts highlight her role as a leading inventor in this critical area of research. Her work continues to pave the way for advancements in treatment and prevention strategies.